We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Epidemiology of Schizophrenia in Bulgaria

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00984373
First Posted: September 25, 2009
Last Update Posted: February 4, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
AstraZeneca
September 24, 2009
September 25, 2009
February 4, 2010
September 2009
November 2009   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00984373 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Epidemiology of Schizophrenia in Bulgaria
Epidemiological Study to Describe Approaches in Diagnosis, Treatment and Social Functioning of Schizophrenic Patients in Bulgaria

The purpose of this study is to provide accurate, reliable information on schizophrenia clinical management in order to detect unmet medical needs of this disease in terms of:

  • Patient characteristics.
  • Diagnostic and treatment approaches: initial and subsequent.
Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Primary Care Clinic
Schizophrenia
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
440
November 2009
November 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with schizophrenia
  • Above 18 years
  • Signed Informed consent

Exclusion Criteria:

  • Below 18 years
  • Consent refused
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Bulgaria
 
 
NCT00984373
NIS-NBG-SER-2009/1
No
Not Provided
Not Provided
MC MD, AstraZeneca
AstraZeneca
Not Provided
Not Provided
AstraZeneca
February 2010